Facebook
Twitter
Telegram
Report an ErrorStrongbridge Biopharma plc Financial Statements 2011-2024 | SBBP
Annual Financial Statements Strongbridge Biopharma plc
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
151 M | 157 M | 219 M | 247 M | 47.4 M | 76.4 M | - | - | - | - |
Shares |
56.1 M | 54.2 M | 46.3 M | 36.5 M | 21.6 M | 16.6 M | - | - | - | - |
Net Income |
-45.1 M | -49.5 M | 31.9 M | -113 M | -48.6 M | -43.6 M | -9.67 M | -5.3 M | - | - |
Revenue |
30.7 M | 21.7 M | 18 M | 7.05 M | - | - | - | - | - | - |
EBITDA |
-38.1 M | -58.8 M | -74.7 M | -48 M | -36.1 M | -42.7 M | -10.2 M | -4.62 M | - | - |
Operating Expenses |
71.7 M | 81.7 M | 96 M | 58.6 M | - | - | - | - | - | - |
General and Administrative Expenses |
40.9 M | 45.8 M | 63.3 M | 36.3 M | 14.9 M | 22.7 M | 4.59 M | - | - | - |
All numbers in USD currency